Hemostatic Gauze, Kaolin-Based

The Defense Logistics Agency (DLA) Troop Support Medical Prime Vendor Program, in collaboration with the Medical Materiel Enterprise Standardization Office (MMESO), is seeking qualified suppliers to establish a Qualified Suppliers Listing (QSL) for Kaolin-Based Hemostatic Gauze products. This initiative aims to identify vendors capable of providing sterile, FDA-cleared, non-latex, x-ray detectable gauze in various sizes, with an estimated annual demand exceeding 7 million units across multiple military medical facilities and operational units. Vendors must demonstrate compliance with the Trade Agreements Act (TAA), possess or be in the process of obtaining a DAPA or DMM number, and have existing agreements with the current DoD Prime Vendors, Cardinal Health and Owens & Minor, to ensure distribution through the MSPV program. The process involves submitting detailed product documentation, including packaging images, labeling, and certification of non-latex composition, by October 17, 2024, for evaluation. Successful vendors will be invited to submit pricing and DAPA documentation for potential inclusion in an Incentive Agreement, which is not a contract but a standardization action to streamline procurement. The initiative emphasizes product quality, compliance, and readiness to support military medical operations, with the goal of establishing a standardized, reliable supply of Kaolin-Based Hemostatic Gauze for the Military Health System.